FDA Drug Recalls

Recalls / Class III

Class IIID-0522-2016

Product

HPMC Visoelastic, 20,000 cps, Reference 5122, 515 (Private Label), 600102-001 (Private Label), 600103-001 (Private Label), 2.0 mL in 3-mL Syringe, OASIS Medical Inc, 514 South Vermont Avenue Glendora, CA 91741

Affected lot / code info
Lot #: V0814H, V0814J, Exp 08/2016; V1014L, Exp 11/2016; V1114A, Exp 11/2016; V0115G, V0115H, Exp 01/2017; V0215A, V0215B, Exp 02/2017; V0315G, V0315H, V0315O, Exp 03/2017; V0515C, V0515D, Exp 05/2017.

Why it was recalled

Failed pH Specification: It has been determined that the pH of the lots recalled, may not meet specification at expiry.

Recalling firm

Firm
Oasis Medical, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
514 S. Vermont Ave Bldg 510-528, N/A, Glendora, California 91741-6205

Distribution

Quantity
15,301 units
Distribution pattern
Nationwide and Saudi Arabia, Israel, Chile, Norway, Ecuador, Greece, Switzerland, Canada, England, Columbia, Poland, South Africa, Germany, Pakistan, El Salvador, Dubai, Belgium

Timeline

Recall initiated
2015-10-19
FDA classified
2015-12-22
Posted by FDA
2015-12-30
Terminated
2016-03-14
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0522-2016. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class III recall: drug · FDA Drug Recalls